In IBD patients an increased IL-22 expression was observed exclusively in ILC3s rather than T cells (63), fortifying the relevance of ILC3-derived IL-22 on gut barrier integrity in humans (Figure 2). The gene discussed is IL22; the disease is inflammatory bowel disease.